UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 14, 2004
GLOBAL MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Colorado
(State or other jurisdiction of
incorporation or organization) | 0-22083
(Commission File No.) | 84-1116894
(I.R.S. Employer
Identification No.) |
12600 West Colfax, Suite C-420, Lakewood, Colorado 80215
(Address of principal executive offices) (Zip Code)
(303) 238-2000
(Registrant’s telephone number, including area code)
Item 7. Financial Statements and Exhibits.
(c) The following exhibits are furnished herewith:
| 99.1 | | Press release, dated May 14, 2004. |
Item 12. Results of Operations and Financial Condition.
The information in this Form 8-K (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
| | On May 14, 2004, Global Med Technologies, Inc. issued a press release announcing its results for the three months ended March 31, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | GLOBAL MED TECHNOLOGIES, INC.
By:/s/ Michael I. Ruxin, M.D.
Michael I. Ruxin, M.D.
Chairman and Chief Executive Officer |
Date: May 17, 2004
2
EXHIBIT INDEX
Exhibit No.
| Description
|
|---|
99.1 | | Press release dated May 14, 2004 issued by Global Med Technologies, Inc. | |
3
